z-logo
open-access-imgOpen Access
S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions--authors' response
Author(s) -
I. S. F. Costa,
Gabriela Freitas Pereira de Souza,
Marcelo G. de Oliveira,
Ises de Almeida Abrahamsohn
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku223
Subject(s) - leishmania braziliensis , amastigote , leishmania , cutaneous leishmaniasis , cytotoxic t cell , microbiology and biotechnology , intracellular , s nitrosoglutathione , leishmania major , leishmaniasis , biology , immunology , medicine , in vitro , glutathione , parasite hosting , biochemistry , world wide web , computer science , enzyme
15-fold compared with control (Figure 1). Chemokines, which coordinate the recruitment of leucocytes involved in homeostasis and in innate and adaptive immune responses, play a crucial role in the regulation of immunity against Leishmania. In addition, CCL3 and CCL20 have been shown to display antiparasitic activity against the promastigote form of the Leishmania mexicana parasite by acting directly on plasma membranes on Leishmania parasites, causing their lysis. Evidence of an increase in phagocytosis and NO-mediated destruction of Leishmania by chemokines (including CCL3 and CCL4) was reported a decade ago. Moreover, we show here that IL-23A levels are induced by GSNO. Murray et al. showed that IL-23 displayed an antileishmanial effect, especially during late-stage parasitic infection. Thus, GSNO may be implicated in a cellular signalling pathway leading to macrophage activation and exhibiting immunostimulatory effects. Our results indicate that GSNO not only exhibits microcidal activity but also acts as a macrophage activator. This activation was possible with the involvement of at least three chemokines (CCL4, CCL3 and CCL20) and one cytokine (IL23A). All of them are known to have antiparasitic activity, and thus could be effective against Leishmania infection. In conclusion, our results may be relevant to investigators working on GSNO antiparasitic activity in vitro and in vivo.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom